Assessment of the usefulness of presepsin (soluble CD14 subtype) in septic patients
Takeshi Nishida(Osaka Prefectural Medical Center), S Endo(Iwate Medical University), Yuhei Irie(Fukuoka University), Hiroyasu Ishikura(Fukuoka University), Akira Murai(Fukuoka University), Rie Yuge(Fukuoka University Hospital), Tetsu Kamitani(SBI Pharmaceuticals (Japan))
Cited by 2
Related Papers
Characterization of NEDD8, a Developmentally Down-regulated Ubiquitin-like Protein
|Journal of Biological Chemistry|1997|532
Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study
|Journal of Infection and Chemotherapy|2012|325
Improved Immunodetection of Endogenous α-Synuclein
|PLoS ONE|2011|167
Presepsin as a powerful monitoring tool for the prognosis and treatment of sepsis: A multicenter prospective study
|Journal of Infection and Chemotherapy|2013|96
Post-Intensive Care Syndrome and Its New Challenges in Coronavirus Disease 2019 (COVID-19) Pandemic: A Review of Recent Advances and Perspectives
|Journal of Clinical Medicine|2021|91